RxDoctor Payments Data

Ferdinand Catotal

Family · Elgin, ILNPI 1538681572

Payments from drug & device makers

$3,590in general payments, 2019–2025

Across 188 payments — averaging $19.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$674
  • Novo Nordisk$546
  • Lilly USA, LLC$393
  • AbbVie$272
  • Pfizer$202
  • Boehringer Ingelheim$190
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$3,56799%
  • Education$231%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,590 in reported general payments places this provider in the 90th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Medicare billing

Part B allowed, 2024
$17,920
Medicare patients
40
Services billed
187

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide44$59,458
JardianceEmpagliflozin36$56,881
EliquisApixaban14$16,305
FarxigaDapagliflozin Propanediol12$15,592
VascepaIcosapent Ethyl28$14,938
LinzessLinaclotide11$13,883
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog25$11,358
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$11,266
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr23$10,928
Breo ElliptaFluticasone/Vilanterol12$7,494
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$3,392
Fenofibrate27$2,629
Mirtazapine17$1,638
Candesartan Cilexetil22$1,217
Losartan Potassium98$1,126

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$546$59,45844 claims
Boehringer IngelheimJardiance$190$56,88136 claims
AstraZenecaFarxiga, Breztri Aerosphere$674$26,85924 claims
PfizerEliquis$202$16,30514 claims
AbbVieLinzess$272$13,88311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,941 family providers in Illinois.

Other family in Elgin

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →